The role of p21-activated kinase in the initiation of atherosclerosis

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Jhaveri, K A ^a   Debnath, P ^a   Chernoff, J ^b   Sanders, J ^a   Schwartz, M A ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Fibronectin; Fluid shear stress; Vascular inflammation

Indexed keywords

BIOLOGICAL MARKER; CELL MARKER; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAC2 PROTEIN; P21 ACTIVATED KINASE; P21 ACTIVATED KINASE 1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THORACIC AORTA; WILD TYPE;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; BIOMECHANICAL PHENOMENA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBRONECTINS; GALECTIN 3; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P21-ACTIVATED KINASES; REGIONAL BLOOD FLOW; TRANSCRIPTION FACTOR RELB; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84868611712     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-55     Document Type: Article

References (20)

1. Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature 1969, 223(5211):1159-60. 10.1038/2231159a0, 5810692.
2. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988, 112(10):1018-31.
3. Garcia-Cardena G, Comander J, Anderson KR, Blackman BR, Gimbrone MA. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A 2001, 98(8):4478-85. 10.1073/pnas.071052598, 31860, 11296290.
4. Helmlinger G, Geiger RV, Schreck S, Nerem RM. Effects of pulsatile flow on cultured vascular endothelial cell morphology. J Biomech Eng 1991, 113(2):123-31. 10.1115/1.2891226, 1875686.
5. Truskey GA, Barber KM, Robey TC, Olivier LA, Combs MP. Characterization of a sudden expansion flow chamber to study the response of endothelium to flow recirculation. J Biomech Eng 1995, 117(2):203-10. 10.1115/1.2796002, 7666657.
6. Paigen B, Ishida BY, Verstuyft J, et al. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 1990, 10:316-323. 10.1161/01.ATV.10.2.316, 2317166.
7. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009, 10(1):53-62. 10.1038/nrm2596, 2719300, 19197332.
8. Cecchi E, Giglioli C, Valente S, Lazzeri C, Gensini GF, Abbate R, Mannini L. Role of hemodynamic shear stress in cardiovascular disease. Atherosclerosis 2011, 214(2):249-256. 10.1016/j.atherosclerosis.2010.09.008, 20970139.
9. Hofmann C, Shepelev M, Chernoff J. The genetics of Pak. J Cell Sci 2004, 117:4343-4354. 10.1242/jcs.01392, 15331659.
10. Jaffer ZM, Chernoff J. p21-activated kinases: three more join the Pak. Int J Biochem Cell Biol 2002, 34(7):713-7. 10.1016/S1357-2725(01)00158-3, 11950587.
11. Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem 2003, 72:743-81. 10.1146/annurev.biochem.72.121801.161742, 12676796.
12. Orr AW, Stockton R, Simmers MB, Sanders JM, Sarembock IJ, Blackman BR, Schwartz MA. Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. J Cell Biol 2007, 176(5):719-27. 10.1083/jcb.200609008, 2064028, 17312022.
13. Orr AW, Hahn C, Blackman BR, Schwartz MA. p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow. Circ Res 2008, 103(6):671. 10.1161/CIRCRESAHA.108.182097, 2697905, 18669917.
14. Hahn C, Orr AW, Sanders JM, Jhaveri KA, Schwartz MA. The subendothelial extracellular matrix modulates JNK activation by flow. Circ Res 2009, 104(8):995-1003. 10.1161/CIRCRESAHA.108.186486, 2702158, 19286608.
15. Sechler JL, Corbett SA, Wenk MB, Schwarzbauer JE. Modulation of cell-extracellular matrix interactions. Ann N Y Acad Sci 1998, 857:143-54. 10.1111/j.1749-6632.1998.tb10114.x, 9917839.
16. Tan MH, Sun Z, Opitz SL, Schmidt TE, Peters JH, George EL. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 2004, 104(1):11-18. 10.1182/blood-2003-09-3363, 14976060.
17. Babaev VR, Porro F, Linton MF, Fazio S, Baralle FE, Muro AF. Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice. Atherosclerosis 2008, 197(2):534-40. 10.1016/j.atherosclerosis.2007.08.015, 2358924, 17897651.
18. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS, Buysschaert I, Carlquist JF, Chen L, Cichon S, Codd V, Davies RW, Dedoussis G, Dehghan A, Demissie S, Devaney JM, Diemert P, Do R, Doering A, Eifert S, Mokhtari NE, Ellis SG, Elosua R, Engert JC, Epstein SE, de Faire U, Fischer M, Folsom AR, Freyer J, Gigante B, Girelli D, Gretarsdottir S, Gudnason V, Gulcher JR, Halperin E, Hammond N, Hazen SL, Hofman A, Horne BD, Illig T, Iribarren C, Jones GT, Jukema JW, Kaiser MA, Kaplan LM, Kastelein JJ, Khaw KT, Knowles JW, Kolovou G, Kong A, Laaksonen R, Lambrechts D, Leander K, Lettre G, Li M, Lieb W, Loley C, Lotery AJ, Mannucci PM, Maouche S, Martinelli N, McKeown PP, Meisinger C, Meitinger T, Melander O, Merlini PA, Mooser V, Morgan T, Mühleisen TW, Muhlestein JB, Münzel T, Musunuru K, Nahrstaedt J, Nelson CP, Nöthen MM, Olivieri O, Patel RS, Patterson CC, Peters A, Peyvandi F, Qu L, Quyyumi AA, Rader DJ, Rallidis LS, Rice C, Rosendaal FR, Rubin D, Salomaa V, Sampietro ML, Sandhu MS, Schadt E, Schäfer A, Schillert A, Schreiber S, Schrezenmeir J, Schwartz SM, Siscovick DS, Sivananthan M, Sivapalaratnam S, Smith A, Smith TB, Snoep JD, Soranzo N, Spertus JA, Stark K, Stirrups K, Stoll M, Tang WH, Tennstedt S, Thorgeirsson G, Thorleifsson G, Tomaszewski M, Uitterlinden AG, van Rij AM, Voight BF, Wareham NJ, Wells GA, Wichmann HE, Wild PS, Willenborg C, Witteman JC, Wright BJ, Ye S, Zeller T, Ziegler A, Cambien F, Goodall AH, Cupples LA, Quertermous T, März W, Hengstenberg C, Blankenberg S, Ouwehand WH, Hall AS, Deloukas P, Thompson JR, Stefansson K, Roberts R, Thorsteinsdottir U, O'Donnell CJ, McPherson R, Erdmann J, Samani NJ, . Cardiogenics CARDIoGRAM Consortium Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 43(4):333-8. 10.1038/ng.784, 3119261, 21378990, Cardiogenics CARDIoGRAM Consortium.
19. Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol 2005, 169(1):191-202. 10.1083/jcb.200410073, 2171897, 15809308.
20. Weih F, Warr G, Yang H, Bravo R. Multifocal defects in immune responses in RelB-deficient mice. J Immunol 1997, 158(11):5211-8.